Type-2 Diabetes Market Size & Insights
The Global Type-2 Diabetes Market size was valued at around USD 52.7 billion in 2024 and is expected to reach USD 72.21 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.39% during the forecast period, i.e., 2025-30.
The market growth is favorably fostered by the increasing prevalence of type 2 diabetes stemming from unhealthy lifestyles, physical inactivity, and obesity. According to WHO, around 422 million people worldwide have diabetes, out of which the majority live in low-and middle-income countries. In addition, diabetes accounts for more than 1.5 million deaths each year.
What are the Key DROs in the Type-2 Diabetes Market?
Rising Global Prevalence of Obesity and Sedentary Lifestyle – A key driver for the Global Type-2 Diabetes Market is the increasing prevalence of obesity and sedentary lifestyles worldwide. Urbanization, changing dietary habits, and reduced physical activity are leading to a surge in obesity rates, which is a major risk factor for type 2 diabetes. This trend is particularly pronounced in both developed and developing nations, contributing to a growing patient pool and heightened demand for diabetes management solutions. As more individuals are diagnosed with type 2 diabetes, the market for medications, monitoring devices, and support services continues to expand rapidly.
What are the Key Segments in the Type-2 Diabetes Market?
The Type-2 Diabetes is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:
By Drug Type
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- Alpha-glucosidase Inhibitors
- Biguanides
- Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
- Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
- Sulfonylureas
- Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)
By Gender
- Male
- Female
Between the two, the female segment held a significant market share in the Global Type-2 Diabetes market in 2024, owing to the alarming rise in the prevalence of type-2 diabetes among pregnant women.
Boost Your Company's Decisions by Getting a Free Sample Right Away- https://www.marknteladvisors.com/query/request-sample/global-type-2-diabetes-market.html
By Age Group
- Upto 19 years
- 20 – 65 years
- Above 65 years
How does geographical analysis highlight in the Type-2 Diabetes market?
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
Here, North America captured a considerable market share in the Global Type-2 Diabetes market in 2024, with the US acquiring the majority market share in the region.
Who are the Key Players in Type-2 Diabetes Market?
- Merck & Co
- AstraZeneca
- Novo Nordisk
- Bristol-Myers Squibb
- Eli Lilly
- Sanofi
- Boehringer Ingelheim
- copyright
- Takeda
- Biocon
- Johnson & Johnson and others.
Browse Full Reports - https://www.marknteladvisors.com/research-library/global-type-2-diabetes-market.html
Type-2 Diabetes Market News
- 2024: Eli Lilly declared a total investment of $9 billion in its Lebanon, Indiana, manufacturing site. The site was expanded to produce APIs such as Zepbound (tirzepatide) injection and Mounjaro (tirzepatide) for the treatment of obesity and type 2 diabetes.
Key pillars of the research methodology include:
- Scope & Research Design – Clearly defined objectives with tailored qualitative and quantitative methods, backed by precise timelines and budgets.
- Sample Selection & Data Collection – Representative samples achieved through proven techniques like random and stratified sampling, supported by reliable tools such as surveys, interviews, and observations.
- Data Analysis & Validation – Rigorous cleaning, advanced statistical modeling, and thematic analysis ensure accuracy, reliability, and minimal bias.
- Forecasting & Finalization – Predictive modeling and time-series analysis anticipate future market behaviors, presented through insightful reports with charts, graphs, and strategic recommendations.
"Our methodology reflects the trust businesses place in us. By combining innovation with precision, we deliver not just numbers, but clarity and direction for decision-makers worldwide," said a spokesperson for MarkNtel Advisors.
Other reports:
Evaluating the Significantly Growing Ovarian Cancer Market
How Lucrative is the Future of the Li-Fi Market?
Why This MarkNtel Advisors Research Report:
- In-depth Market Analysis: Understand trends and dynamics shaping growth.
- Segmented Insights: Target specific segments for focused strategies.
- Geographical Performance: Assess market opportunities by geographic area.
- Emerging Technologies: Discover advancements like AI integration.
- Risk Identification: Pinpoint challenges to inform strategic planning.
- Future Forecasts: Prepare for market changes with actionable projections.
Gain exclusive access to our comprehensive insights on the Future of Type-2 Diabetes Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.
Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/global-type-2-diabetes-market.html
Our Trusted Experts Are Here to Help:
At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.
Reach Us:
MarkNtel Advisors
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 8719999009
Email: [email protected]
Visit our Website: https://www.marknteladvisors.com
We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.